Trichomonas Vaginitis, and its Treatment with Tinidazole

  • P. E. R. Rhemrev
  • F. Kosasih
Part of the Chemotherapy book series (CT, volume 3)


Fifty-one patients with trichomonal vaginitis diagnosed by microscopicevaluation of the vaginal fluor were treated with Fasigyn (tinidazole)either in a cure of seven days 150mg. b.i.d., or in a single dose of2000mg. Both groups showed a cure-rate of 100% one week after initiation of the treatment. In the 7 day-group the cure-rate was still 100% 4 weeks after treatment as was the case in the single dose group on the 10th dayof the menstrual cycle following treatment. Eight weeks after treatment the cure-rates were 92% and 73%.

In the single dose group 3 patients showed nausea. As most patients from both groups had either recidivating or chronic vaginitis which had already been treated before these results are certainly warranting the use of Fasigyn as a first choice agent in the treatment of Trichomonas vaginalis infections.


Sexual Partner Menstrual Cycle Vaginal Discharge Male Sexual Partner Mucosal Gland 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Trichomonas-Vaginitis. Nadere behandelingsmogelijkheden. J.Daels et al. Tijdschrift voor Geneeskunde 15–26e jaargang-1. 8. 70.Google Scholar
  2. 2.
    Trichomoniasis - Behandelung der Frau mit Tinidazole. J.Diwald. Wiener Medizinische Wochenschrift.121 (1971) no.24 (492)Google Scholar
  3. 3.
    History of the treatment of trichomoniasis. Robert Forgan. Brit.J.vener. Dis. (1972) 48, 522.Google Scholar
  4. 4.
    Zur Behandlung der Trichomoniasis beim Mann. J.Frick et al. Therapie Woche 21,6, 472 (1971).Google Scholar
  5. 5.
    Tinidazole, a New Antiprotozoal Agent: Effect on Trichomonas and other Protozoa. H.L.Howes, Jr.,et al. Antimicrobial Agents and Chemotherapy- 1969,p. 261.Google Scholar
  6. 6.
    Perorale Behanlung der Trichomonadenkolpitis mit Fasigyn. R.Liechti. Schweiz.Z.Gynäk.Geburtsh. 2, 229–235 (1971).Google Scholar
  7. 7.
    Tinidazole, a Potent New Antiprozoal Agent. M.W.Miller et al. Antimicrobial Agents and Chemotherapy - 1969, 257.Google Scholar
  8. 8.
    Tinidazole and Metronidazole Pharmacokinetics in Man and Mouse. J.A.Taylor et al. Anticrobial Agents and Chemotherapy - 1969, 267.Google Scholar
  9. 9.
    The Pharmacokinetics of Metronidazole and Tinidazole in Man. P.G.Welling et al. Arzneimittel–Forschung (Drug research) 22, 2128–2132 (1972).Google Scholar

Copyright information

© Plenum Press, New York 1976

Authors and Affiliations

  • P. E. R. Rhemrev
    • 1
  • F. Kosasih
    • 1
  1. 1.Dept. for Gynaecology and ObstetricsSt. Elisabeth GasthuisHaarlemThe Netherlands

Personalised recommendations